16 April 2021 : Clinical Research
An Observational Cohort Study of the 2-Month Use of Regional Citrate Anticoagulation in Maintenance Hemodialysis Patients with Cerebral Hemorrhage
Xiao Bi1ABCDEF, Qi Zhang1ABE, Feng Zhuang1B, Wei Lu1B, Yingdeng Wang1AE, Feng Ding1ADE*DOI: 10.12659/MSM.930513
Med Sci Monit 2021; 27:e930513
Table 1 Baseline characteristics of patients included in the cohort.
| Parameter | Normal range | Mean (SD) |
|---|---|---|
| Age (years) | / | 65±17 |
| Gender (Male, %) | / | 57% |
| White blood cell (×10/L) | 3.5–9.5 | 5.1±1.4 |
| Hemoglobin (g/L) | 130–175 | 90±12 |
| Hematocrit (%) | 40–50 | 28±4 |
| ALT (U/L) | 10–49 | 10±2 |
| AST (U/L) | 0–34 | 17±2 |
| Bilirubin (mmol/L) | 5–21 | 6±3 |
| Albumin (g/L) | 35–50 | 37±4 |
| BUN (mmol/L) | 2.5–6.4 | 25.2±7.6 |
| Scr (umol/L) | 55–96 | 657±274 |
| Serum phosphate (mmol/L) | 0.78–1.65 | 1.7±0.4 |
| Serum total calcium (mmol/L) | 2.08–2.65 | 2.4±0.4 |
| SD – standard deviation; ALT – alanine aminotransferase; AST – aspartate aminotransferase; BUN – blood urea nitrogen; Scr – serum creatine. | ||